Related Experiment Videos
Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human
T Krakauer1, B Fleischer, D L Stevens
1Department of Immunology and Molecular Biology, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
Abstract:
We investigated the potential superantigenic properties of Clostridium perfringens enterotoxin (CPE) on human peripheral blood mononuclear cells (PBMC). In contrast to the findings of a previous report (P. Bowness, P. A. H. Moss, H. Tranter, J. I. Bell, and A. J. McMichael, J. Exp. Med. 176:893-896, 1992), two different, biologically active preparations of CPE had no mitogenic effects on PBMC. Furthermore, PBMC incubated with various concentrations of CPE did not elicit interleukin-1, interleukin-2, gamma interferon, or tumor necrosis factor alpha or beta, which are cytokines commonly associated with superantigenic stimulation. However, CPE did cause a dose-related release of interleukin-6 from PBMC cultures.
Insights
Clostridium perfringens enterotoxin (CPE) did not stimulate human peripheral blood mononuclear cells (PBMC) as a superantigen. However, CPE did induce a dose-related release of interleukin-6 from PBMC cultures.
Area of Science:
- Immunology
- Microbiology
- Toxicology
Background:
- Clostridium perfringens enterotoxin (CPE) is a protein implicated in gastrointestinal diseases.
- Superantigens are potent immune activators that can trigger widespread cytokine release.
- Previous studies suggested potential superantigenic properties of CPE.
Purpose of the Study:
- To investigate the superantigenic potential of Clostridium perfringens enterotoxin (CPE) on human peripheral blood mononuclear cells (PBMC).
- To determine if CPE induces mitogenic effects or the release of specific cytokines associated with superantigenic activity.
Main Methods:
- Human peripheral blood mononuclear cells (PBMC) were incubated with biologically active preparations of CPE.
- Cell proliferation (mitogenesis) was assessed.
- Culture supernatants were analyzed for the presence of key cytokines including interleukin-1, interleukin-2, gamma interferon, and tumor necrosis factor alpha/beta, and interleukin-6.
Main Results:
- CPE did not exhibit mitogenic effects on PBMC, contrary to previous reports.
- PBMC incubated with CPE did not release common superantigen-associated cytokines (IL-1, IL-2, IFN-γ, TNF-α/β).
- A dose-related release of interleukin-6 (IL-6) was observed from PBMC cultures treated with CPE.
Conclusions:
- CPE does not appear to function as a classical superantigen in human PBMC.
- The observed IL-6 release suggests a distinct immunomodulatory mechanism for CPE, independent of superantigenic activity.
- Further research is warranted to elucidate the specific pathways involved in CPE-induced IL-6 production.